-- Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients suffering from Alzheimer’s disease is predicted to grow during the forecasting period. Alzheimer's treatment is a high risk, high reward market. Drugs currently available in the market have reached maturity; patent of leading drugs have expired. The current unmet needs represent a huge opportunity for pharmaceutical companies which are developing targeted novel therapies.
Get a premium sample report at https://www.businessindustryreports.com/sample-request/6615
Global Alzheimer’s Disease Drugs Market and Pipeline Drugs Analysis
In 2016, the global market for Alzheimer’s disease drugs was dominated by Namenda, Memary, Aricept and Exelon. The combined market share of these four drugs was over 80% in the year 2016.
Ebixa, Razadyne/Reminyl, Rivastach and Nootropil are the other popular drugs in the Alzheimer’s disease market.
with the patent expiration of popular drugs the sales of the Alzheimer’s drugs have also declined. However, there are several pipeline drugs like Gantenerumab, Crenezumab and Aducanumab among others which are likely to hit the market during the period 2019 - 2020.
Global Alzheimer’s Disease Country Wise Analysis
In the Alzheimer’s disease drugs market, the United States is the largest market.
Japan is the second leading market for Alzheimer’s disease drugs market accounting for XXX% market share in 2016.
China stands at the third spot in the global Alzheimer’s disease drugs market being followed by India with XXX% share in the same year.
The EU5 countries together accounted for over 10% share of the global Alzheimer’s disease drugs market in 2016.
Purchase this report at https://www.businessindustryreports.com/buy-now/6615/single .
Alzheimer’s Disease Drugs Market, Regional Analysis & Forecast, Major Deals & Funding, and Pipeline Drugs Analysis to 2021Â is a 189 Page report with 74 Figures and 14 Tables. This report provides a comprehensive assessment of the Alzheimer’s Disease Drugs Market, Alzheimer’s Disease Pipeline Drugs Market and Clinical Trials Analysis, Alzheimer’s Disease - Country Wise Drugs Market, Country Wise Alzheimer’s Disease Prevalence, Major Deals in Alzheimer’s Disease Drugs Market Landscape, Funding in Alzheimer’s Disease Drugs Research, Driving Factors and Challenges for Alzheimer’s Disease Drugs Market.
The Alzheimer’s Disease Drugs Market has been analyzed from 8 View Points:
1. Alzheimer’s Disease - Drugs Sales and Forecast
2. Alzheimer’s Disease - Pipeline Drugs Sales Forecast
3. Alzheimer’s Disease Drugs - Country Wise Market and Forecast
4. Alzheimer’s Disease - Country Wise Prevalence and Forecast
5. Alzheimer’s Disease  List of Pipeline Drugs in Various Phase of Development
6. Alzheimer’s Disease - Major Deals in Alzheimer’s Drugs Market
7. Alzheimer’s Disease - Funding in Alzheimer’s Disease Research
8. Alzheimer’s Disease Drugs Market  Driving Factors & Challenges
More inquire at https://www.businessindustryreports.com/enquiry/6615 .
The Top 9 Alzheimer’s Disease Drugs covered in the report are as follows:
1. Exelon
2. Razadyne/Reminyl
3. Memary
4. Ebixa
5. Aricept
6. Rivastach
7. Namenda
8. Nootropil
9. Namzaric
Major Table of Content
Executive Summary
Global Alzheimer’s Disease - Drugs Market and Prevalence Analysis
Global Alzheimer’s Disease - Country Wise Market Share and Forecast (2013 - 2021)
Global Alzheimer’s Disease - Drugs Sales and Forecast To 2021
Global Alzheimer’s Disease - Pipeline Drugs Analysis and Sales Forecast
Alzheimer’s Disease Drugs Market and Prevalence - Country Wise Analysis
Alzheimer's Disease Drug Development Pipeline: 2017
Global Alzheimer’s Disease Drugs Market - Major Deals Analysis
Global Alzheimer’s Disease Drugs Research - Funding Analysis
Global Alzheimer’s Disease Drug Market - Driving Factors
Global Alzheimer’s Disease Drug Market – Challenges
About us
BusinessIndustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.
Contact Info:
Name: Business Industry Reports
Email: Send Email
Organization: Business Industry Reports
Address: Pune – India
Phone: +19376349940
Website: https://www.businessindustryreports.com/report/6615/global-alzheimers-disease-drugs-market-regional-analysis-forecast-major-deals-funding-and-pipeline-drugs-analysis-to-2021
Release ID: 364978
Google
RSS